1.
$336.4 million Powerball jackpot unclaimed
MINNEAPOLIS, March 8 (UPI) -- Minnesota pharmaceutical company Humanetics Corp. received a patent for its radiation countermeasure drug in case of a nuclear or radiological attack.
Humanetics says its BIO 300 drug candidate has been approved for a patent in the United States. The announced patent for the nuclear or radiological terrorist attack medical radiation countermeasure drug candidate follows patents in Europe and Australia marking a milestone for the development of the drug.
The BIO 300, exclusively licensed by Humanetics following its original development by the Armed Forces Radiobiology Research Institute, is designed to ionize radiation resulting from a nuclear or radiological incident.
"We are pleased that BIO 300 has reached this critical milestone," Ronald Zenk, Humanetics president and chief executive officer, said in a statement.
"There is an urgent need for a safe and practical countermeasure to protect against the devastating effects of both lethal and non-lethal doses of ionizing radiation."
|
|
|
|
|
|
| Additional Security Industry Stories | |
PARIS, Feb. 15 (UPI) --
Though expectations are dampened, oil production from Saudi Arabia could hold steady as the government pumps more money into the oil sector, the IEA said.
|
SINGAPORE, Feb. 15 (UPI) --
Eight of the Thai army's Bell 212 helicopters are to be modified and refurbished in-country under a contract announced this week.
|
Compared to whites, greater shares of both black and Hispanic young adults say owning their own home is among their top priorities. While 25 percent of blacks and 26 percent of Hispanics say owning a home is of the highest importance in their lives,...
|
How does one upset the economic apple cart if one is in a hurry to do so?
|
| Stories | Photos | People | Comments |
View Caption
